Treatment with 1 μM α-MSH induced an increase in melanin content in B16F10 melanoma cells, and co-treatment with MHY1498 marginally decreased melanin content in a dose-dependent manner (Figure 6a). The gene discussed is STAMBP; the disease is melanoma.